Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Travere Therapeutics Inc 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 USA

www.travere.com Employees: 385 P: 888-969-7879

Sector:

Medical

Description:

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 2,493,585
Enterprise Value, $K 2,435,045
Shares Outstanding, K 89,472
Float, K 85,723
% Float 95.81%
Short Interest, K 14,313
Short Float 16.00%
Days to Cover 7.31
Short Volume Ratio 0.44
% of Insider Shareholders 4.19%

Financials:

Annual Sales, $ 233,180 K
Annual Net Income, $ -321,550 K
Last Quarter Sales, $ 164,860 K
Last Quarter Net Income, $ 25,710 K
EBIT, $ -91,130 K
EBITDA, $ -50,380 K

Growth:

1-Year Return 52.10%
3-Year Return 27.70%
5-Year Return 10.65%
5-Year Revenue Growth 32.99%
5-Year Earnings Growth -17.63%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.28 on 10/30/25
Next Earnings Date 02/19/26
Earnings Per Share ttm -1.06
EPS Growth vs. Prev Qtr 300.00%
EPS Growth vs. Prev Year 140.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TVTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 53.85
Price/Earnings to Growth 1.01
Return-on-Equity % -178.68%
Return-on-Assets % -15.83%
Profit Margin % -137.90%
Debt/Equity 0.00
Price/Sales 5.60
Price/Cash Flow N/A
Price/Book 33.90
Book Value/Share 0.82
Interest Coverage -27.67
60-Month Beta 0.85
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar